IL10 and neoplasm: In the context of melanoma, in vivo studies in B16-F10 tumor-bearing mice have shown that adenosine signaling through the A2A adenosine receptor on DC is associated with a slight decrease in MHC II and IL-12 expression and a significant increase in the expression of IL-10 (177).